IDH1 and acute myeloid leukemia: Mutations in IDH1 had an adverse impact on OS in HR NK-AML patients in univariate analysis (15% vs 36% for IDH1+ vs IDH1−; p = 0.03; Fig. 1B, Supplemental Table S1).